Norden Group LLC Acquires Shares of 10,324 National Research Co. (NASDAQ:NRC)

Norden Group LLC bought a new position in shares of National Research Co. (NASDAQ:NRC) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,324 shares of the company’s stock, valued at approximately $182,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. FMR LLC boosted its holdings in National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after purchasing an additional 2,352 shares during the last quarter. Gladius Capital Management LP increased its position in shares of National Research by 164.5% during the third quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock valued at $70,000 after acquiring an additional 1,908 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in National Research during the third quarter worth $88,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in National Research in the third quarter worth $96,000. Finally, SG Americas Securities LLC grew its stake in National Research by 35.0% in the 4th quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock valued at $129,000 after purchasing an additional 1,893 shares during the period. 47.26% of the stock is owned by institutional investors.

National Research Stock Performance

NASDAQ NRC opened at $14.23 on Thursday. The company has a market capitalization of $334.06 million, a PE ratio of 13.55 and a beta of 0.47. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research Co. has a 52-week low of $13.74 and a 52-week high of $40.77. The company has a 50-day simple moving average of $16.90 and a 200 day simple moving average of $18.92.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.